article thumbnail

Stellantis, Leapmotor officially launch joint venture to sell Chinese EVs in Europe this fall

Baua Electric

The new JV, named “Leapmotor International,” will expand to sell Chinese EVs in Europe this fall, with additional markets to follow. billion stake in Chinese OEM Leapmotor. Source: Leapmotor International Leapmotor Intl. Today’s event is merely a confirmation of a launch we’ve been expecting for quite some time.

Chinese 52
article thumbnail

Beijing Foton launches “China Internet Super Truck Global Innovation Alliance”; Auman Energy Super Truck

Green Car Congress

Chinese truck and utility vehicle manufacturer Beijing Foton has launched the China Internet Super Truck Global Innovation Alliance and showcased the Auman EST (Energy Super Truck) at an event in Athens, Greece. and Daimler AG at the Beijing International Automotive Exhibition in April.

Global 150
article thumbnail

Stellantis-Leapmotor announces global expansion, to enter India by Q4 of 2024 | Autocar Professional

Baua Electric

Carlos Tavares, Stellantis’ global CEO, has announced that Leapmotor will enter the Indian market in Q4 of 2024 as part of Leapmotor International’s global expansion strategy. This Leapmotor International joint venture aims to sell and manufacture Leapmotor vehicles outside China. Leapmotor, which sold a 20% stake for €1.5

India 52
article thumbnail

The 25 Best Restaurants in Chicago Right Now

Baua Electric

The menu reads like roll call at the United Nations: soups from Indonesia, chickpea tagines, French omelets and a bucatini dish by way of Greece, pairing brown butter with feta and cinnamon. His mother is Chinese, his father Creole. The parents of the executive chef, Chris Jung, are Korean.

Chicago 52
article thumbnail

Battelle-R&D Magazine forecast predicts 5.2% growth in 2012 global R&D spending to $1.4+T, largely driven by Asian economies; US companies and tech providers to boost energy R&D spending by 23.1% to $6.7B

Green Car Congress

Greece is the only country among the world’s top 40 R&D spenders that is not expected to increase its R&D budget during the next year. It is due, in part, to the pharmaceutical industry’s retrenchment from its conventional model to a more reduced internal R&D function and focuses more on collaboration and ROI.

2012 277